Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma (N.Y.P., I.R., A.D.J.); and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas (H.T., K.Z.).
Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma (N.Y.P., I.R., A.D.J.); and Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas (H.T., K.Z.)
Mol Pharmacol. 2022 Jan;101(1):45-55. doi: 10.1124/molpharm.121.000376. Epub 2021 Nov 11.
Aryl hydrocarbon receptor (AhR) is a ligand-mediated transcription factor known for regulating response to xenobiotics, including prototypical 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the activation of CYP1A1 expression. Upon ligand-binding, AhR translocates to the nucleus, interacts with the AhR nuclear translocator, and binds to xenobiotic response elements (XREs; GCGTG) present in the promoter region of AhR-regulated genes. Recently, we identified a novel tryptophan catabolite, cinnabarinic acid (CA), as an endogenous AhR agonist capable of activating expression of AhR target gene stanniocalcin 2 (stc2). The CA-driven stc2 induction bestowed cytoprotection against hepatotoxicity in an AhR-dependent manner. Interestingly, only CA but not TCDD was able to induce stc2 expression in liver, and CA was unable to upregulate the TCDD responsive cyp1a1 gene. In this report, we identified CA-specific histone H4 lysine 5 acetylation and H3 lysine 79 methylation at the AhR-bound stc2 promoter. Moreover, histone H4 lysine 5 acetylation writer, activating transcription factor 2 (Atf2), and H3 lysine 79 methylation writer, disruptor of telomeric silencing 1-like histone lysine methyltransferase (Dot1l), were interacting with the AhR complex at the stc2 promoter exclusively in response to CA treatment concurrent with the histone epigenetic marks. Suppressing Atf2 and Dot1l expression using RNA interference confirmed their role in stc2 expression. CRISPR/Cas9-assisted replacement of cyp1a1 promoter-encompassing XREs with stc2 promoter XREs resulted in CA-dependent induction of cyp1a1, underlining a fundamental role of quaternary structure of XRE sequence in agonist-specific gene regulation. In conclusion, CA-driven recruitment of specific chromatin regulators to the AhR complex and resulting histone epigenetic modifications may serve as a molecular basis for agonist-specific stc2 regulation by AhR. SIGNIFICANCE STATEMENT: Results reported here provide a mechanistic explanation for the agonist-specific differential gene regulation by identifying interaction of aryl hydrogen receptor with specific chromatin regulators concomitant with unique histone epigenetic marks. This study also demonstrated that the agonist-specific target-gene expression can be transferred with the gene-specific promoter xenobiotic response element-sequence in the context of chromatin architecture.
芳香烃受体 (AhR) 是一种配体介导的转录因子,已知其可调节对异源物的反应,包括典型的 2,3,7,8-四氯二苯并对二恶英 (TCDD),通过激活 CYP1A1 的表达。配体结合后,AhR 易位到细胞核,与 AhR 核转位蛋白相互作用,并与 AhR 调节基因启动子区域中的异源物反应元件 (XRE; GCGTG) 结合。最近,我们发现一种新型色氨酸代谢产物,肉桂酸 (CA),作为一种内源性 AhR 激动剂,能够激活 AhR 靶基因 stanniocalcin 2 (stc2) 的表达。CA 驱动的 stc2 诱导以 AhR 依赖的方式赋予细胞对抗肝毒性的保护作用。有趣的是,只有 CA 而不是 TCDD 能够在肝脏中诱导 stc2 表达,而 CA 不能上调 TCDD 响应的 cyp1a1 基因。在本报告中,我们在 AhR 结合的 stc2 启动子上鉴定了 CA 特异性组蛋白 H4 赖氨酸 5 乙酰化和 H3 赖氨酸 79 甲基化。此外,组蛋白 H4 赖氨酸 5 乙酰化写入器激活转录因子 2 (Atf2) 和 H3 赖氨酸 79 甲基化写入器端粒沉默 1 样组蛋白赖氨酸甲基转移酶 1 样 (Dot1l),仅在响应 CA 处理时与 AhR 复合物相互作用,同时伴随着组蛋白表观遗传标记。使用 RNA 干扰抑制 Atf2 和 Dot1l 的表达证实了它们在 stc2 表达中的作用。CRISPR/Cas9 辅助将包含 cyp1a1 启动子的 XRE 替换为 stc2 启动子 XRE,导致 CA 依赖性诱导 cyp1a1,这突出了 XRE 序列四级结构在激动剂特异性基因调节中的基本作用。总之,CA 驱动的特定染色质调节剂募集到 AhR 复合物,并导致组蛋白表观遗传修饰,可能作为 AhR 特异性诱导 stc2 调节的分子基础。
本研究通过鉴定芳香烃受体与特定染色质调节剂的相互作用以及独特的组蛋白表观遗传标记,为激动剂特异性差异基因调节提供了机制解释。该研究还表明,在染色质结构的背景下,激动剂特异性靶基因表达可以与基因特异性启动子异源物反应元件序列转移。